Rite Aid Corporation
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care pr… Read more
Rite Aid Corporation (RTA1) - Net Assets
Latest net assets as of August 2023: €-1.97 Billion EUR
Based on the latest financial reports, Rite Aid Corporation (RTA1) has net assets worth €-1.97 Billion EUR as of August 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€7.13 Billion) and total liabilities (€9.09 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €-1.97 Billion |
| % of Total Assets | -27.59% |
| Annual Growth Rate | N/A |
| 5-Year Change | -154.08% |
| 10-Year Change | N/A |
| Growth Volatility | 289.12 |
Rite Aid Corporation - Net Assets Trend (2017–2023)
This chart illustrates how Rite Aid Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Rite Aid Corporation (2017–2023)
The table below shows the annual net assets of Rite Aid Corporation from 2017 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-02-28 | €-641.78 Million | -748.04% |
| 2022-02-28 | €99.03 Million | -83.90% |
| 2021-02-28 | €615.15 Million | -8.80% |
| 2020-02-29 | €674.53 Million | -43.16% |
| 2019-02-28 | €1.19 Billion | -25.88% |
| 2018-02-28 | €1.60 Billion | +160.72% |
| 2017-02-28 | €614.07 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Rite Aid Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 136436000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (February 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €56.63 Million | % |
| Other Components | €5.90 Billion | % |
| Total Equity | €-641.78 Million | 100.00% |
Rite Aid Corporation Competitors by Market Cap
The table below lists competitors of Rite Aid Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Triniti Dinamik PT Tbk
JK:TRUE
|
$11.16 Million |
|
Boustead Heavy Industries
KLSE:8133
|
$11.17 Million |
|
Dan Hotels
TA:DANH
|
$11.17 Million |
|
First Tellurium Corp
OTCQB:FSTTF
|
$11.17 Million |
|
Niche Capital Emas Holdings
KLSE:7139
|
$11.16 Million |
|
Platinex Inc
F:9PX
|
$11.16 Million |
|
EBM Technologies Incorporated
TWO:8409
|
$11.16 Million |
|
Alpha One Inc
PINK:AOAO
|
$11.15 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Rite Aid Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 99,033,000 to -641,776,000, a change of -740,809,000 (-748.0%).
- Net loss of 749,936,000 reduced equity.
- Other factors increased equity by 9,127,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-749.94 Million | -116.85% |
| Other Changes | €9.13 Million | +1.42% |
| Total Change | €- | -748.04% |
Book Value vs Market Value Analysis
This analysis compares Rite Aid Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-02-28 | €11.66 | €0.20 | x |
| 2018-02-28 | €30.00 | €0.20 | x |
| 2019-02-28 | €21.97 | €0.20 | x |
| 2020-02-29 | €12.33 | €0.20 | x |
| 2021-02-28 | €11.16 | €0.20 | x |
| 2022-02-28 | €1.78 | €0.20 | x |
| 2023-02-28 | €-11.33 | €0.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Rite Aid Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3.11%
- • Asset Turnover: 3.20x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-85.93%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 0.66% | 0.01% | 2.83x | 18.88x | €-57.35 Million |
| 2018 | 58.93% | 4.38% | 2.39x | 5.61x | €783.37 Million |
| 2019 | -35.58% | -1.95% | 2.85x | 6.40x | €-540.88 Million |
| 2020 | -67.04% | -2.06% | 2.32x | 14.01x | €-519.63 Million |
| 2021 | -14.78% | -0.38% | 2.58x | 15.18x | €-152.42 Million |
| 2022 | -543.74% | -2.19% | 2.88x | 86.12x | €-548.38 Million |
| 2023 | 0.00% | -3.11% | 3.20x | 0.00x | €-685.76 Million |
Industry Comparison
This section compares Rite Aid Corporation's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $950,809,000
- Average return on equity (ROE) among peers: -92.95%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Rite Aid Corporation (RTA1) | €-1.97 Billion | 0.66% | N/A | $11.16 Million |
| YSB Inc. (B1S) | $1.88 Billion | -170.24% | 1.77x | $145.06 Million |
| Redcare Pharmacy NV (RDC) | $18.08 Million | -15.66% | 0.42x | $587.80 Million |